Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...
A Phase 1 clinical trial that is investigating a new vaccine against the Epstein-Barr virus (EBV), a well-established risk ...
Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback